CLYM

Climb Bio, Inc. Common Stock

35 hedge funds and large institutions have $182M invested in Climb Bio, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 14 increasing their positions, 7 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
35
Holders Change
+3
Holders Change %
+9.38%
% of All Funds
0.54%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
6
Increased
14
Reduced
7
Closed
3
Calls
Puts
Net Calls
Net Calls Change